A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours
Hollebecque, Antoine, Houédé, Nadine, Cohen, Ezra E.W, Massard, Christophe, Italiano, Antoine, Westwood, Paul, Bumgardner, William, Miller, Joel, Brail, Les H, Benhadji, Karim A, Soria, Jean-Charles
Published in European journal of cancer (1990) (01.03.2014)
Published in European journal of cancer (1990) (01.03.2014)
Get full text
Journal Article
A phase I dose-escalation and pharmacokinetic (PK) evaluation of an oral AKT inhibitor, LY2503029 (LY)
Limentani, S. A., Burris, H., Anderson, A. P., Brail, L. H., Satonin, D., Gueorguieva, I., Jones, S., Infante, J. R., Bendell, J. C.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A phase I dose-escalation, pharmacokinetic (PK), and pharmacodynamic (PD) evaluation of intravenous LY2090314 a GSK3 inhibitor administered in combination with pemetrexed and carboplatin
Brail, L. H., Gray, J. E., Burris, H., Simon, G. R., Cooksey, J., Jones, S. F., Farrington, D., Lam, T., Jackson, K., Chow, K., Brandt, J. T., Infante, J. R.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Randomized phase II trial of cisplatin/gemcitabine with or without LY293111, a multiple eicosonaid pathway modulator, in patients with chemotherapy naïve advanced non-small cell lung carcinoma
Janne, P. A., Paz-Ares Rodriguez, L., Gottfried, M., Reaume, M. N., Kaukel, T., Oh, Y. W., Sykes, A., Enas, N., Brail, L. H., Von Pawel, J.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article